The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs.

A notification issued by Directorate General of Foreign Trade, M/o Commerce and Industry says that the restrictions will come into immediate effect and until further orders.  The notification covers following APIs and formulations made from these APIs:

1. Paracetamol
2. Tinidazole
3. Metronidazole
4. Acyclovir
5. Vitamin B1
6. Vitamin B6
7. Vitamin B12
8. Progesterone
9. Chloramphenicol
10. Erythromycin Salts
11. Neomycin
12. Clindamycin Salts
13. Ornidazole

Export restrictions on specified pharmaceutical APIs and formulations take immediate effect, limiting outbound shipments nationwide. Amendment imposes export restrictions on specified Active Pharmaceutical Ingredients (APIs) and formulations derived from them, effective immediately until further orders, covering Paracetamol; Tinidazole; Metronidazole; Acyclovir; Vitamin B1; Vitamin B6; Vitamin B12; Progesterone; Chloramphenicol; Erythromycin Salts; Neomycin; Clindamycin Salts; and Ornidazole, thereby constraining exports of both bulk APIs and formulations.